Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - WILLIS TOWERS WATSON PLC

5th Jul 2021 12:40

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

WILLIS TOWERS WATSON PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

ORD

Date of dealing

2 JULY 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD
LongShort
Number(%)Number(%)

(1)

Relevant securities

1,860,766

1.44%

240,520

0.19%

 

(2)

Derivatives (other than options):

72,359

0.06%

227,408

0.18%

 

(3)

Options and agreements to
purchase/sell:

6,100

0.00%

6,100

0.00%

 

(4)

TOTAL:

1,939,225

1.50%

474,028

0.37%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/saleNumber of relevant securitiesPrice per unit
Purchase

1

233.9300 USD
Purchase

1

231.7200 USD
Purchase

1

232.2600 USD
Purchase

2

231.6700 USD
Purchase

2

232.2250 USD
Purchase

2

231.8350 USD
Purchase

2

232.6500 USD
Purchase

2

232.1450 USD
Purchase

2

232.4700 USD
Purchase

2

231.8300 USD
Purchase

3

232.3900 USD
Purchase

3

231.7900 USD
Purchase

5

231.7120 USD
Purchase

5

232.2980 USD
Purchase

6

232.0983 USD
Purchase

13

231.8461 USD
Purchase

22

232.3459 USD
Purchase

50

232.2830 USD
Purchase

67

231.7402 USD
Purchase

94

231.6990 USD
Purchase

127

231.3905 USD
Purchase

152

232.7059 USD
Purchase

163

232.0305 USD
Purchase

197

233.2500 USD
Purchase

198

231.7600 USD
Purchase

200

231.8450 USD
Purchase

200

231.6550 USD
Purchase

250

231.7720 USD
Purchase

300

231.7440 USD
Purchase

614

231.8616 USD
Purchase

797

232.5072 USD
Purchase

846

232.4573 USD
Purchase

1,302

232.1999 USD
Purchase

1,661

231.9808 USD
Purchase

2,434

231.5636 USD
Purchase

5,536

231.8853 USD
Purchase

10,150

231.7000 USD
Sale

1

231.8700 USD
Sale

2

231.9000 USD
Sale

2

232.6500 USD
Sale

58

232.1279 USD
Sale

67

232.1338 USD
Sale

97

232.0200 USD
Sale

163

232.0305 USD
Sale

200

233.2562 USD
Sale

214

231.8604 USD
Sale

250

231.7720 USD
Sale

646

232.2099 USD
Sale

946

232.5410 USD
Sale

1,702

232.0937 USD
Sale

2,331

231.7009 USD
Sale

2,737

231.5911 USD
Sale

7,555

231.7000 USD
Sale

7,695

231.8973 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure

5 JULY 2021

Contact name

Large Holdings Regulatory Operations

Telephone number

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product nameWritten orNumber ofExerciseTypeExpiry
purchasedrelevant securitiespricedate
to which the option
or derivative
relates
Put OptionsPurchased

-100

220.0000

AmericanJul 16, 2021
Call OptionsPurchased

100

240.0000

AmericanJul 16, 2021
Call OptionsPurchased

6,000

220.0000

AmericanJul 16, 2021
Put OptionsPurchased

-6,000

200.0000

AmericanJul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210705005134/en/

Copyright Business Wire 2021


Related Shares:

Barclays
FTSE 100 Latest
Value8,833.29
Change22.25